What this means
This trial plans to study whether exercise helps muscle loss linked to cancer. It has not started, so it cannot yet tell us if exercise works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 18 and over
- Where
- 1 site
The science
- Registered title
- Exercise for the Treatment of Cancer-Related Sarcopenia
- Trial ID
- NCT07498985 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Cancer, Sarcopenia
- What is tested
- Multimodal, supervised exercise training
- Sponsor
- State University of Londrina
- Ages
- 18 Years to no maximum
- Dates
- First posted Mar 27, 2026 · updated Mar 27, 2026
Registry summary
Our primary objective is to assess the effects of exercise on cancer-related sarcopenia and its hallmarks, including muscle strength, muscle mass, and physical performance. The secondary objectives are to examine exercise adherence and the effects of exercise on health-related quality of life (QoL), cancer-related fatigue, and sleep quality. Additionally, we will explore the effects of exercise on bone and fat mass as secondary outcomes.
Sites (1)
- State University of Londrina, Londrina, Paraná, Brazil